Don ’t foresee any disruptions due to Covid-19: Vasant Narasimhan, CEO, Novartis
Novartis is one of the oldest pharma MNCs known for anti-cancer and anti-diabetic drugs. Despite the patent expiry for its popular anti-diabetic drug Galvus, Narasimhan is upbeat about Novartis ’ India prospects.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Diabetes | Endocrinology | India Health | Pharmaceuticals